Fake MDMA Warning 24 Feb 2017

pink.clear_.cap_.feb17

An Ultra Alert Health Advisory has been issued by the ACTINOS Project (Canberra) for Pink & Clear Capsules sold as MDMA, containing brown coarse granular material which was identified as Flouroamphetamine and 25C-NBOMe. A person who consumed this drug combination was admitted to hospital suffering convulsions.

These capsules contained no MDMA, although capsules involved in the recent Chapel Street overdose incident in Melbourne (January 2017) contained a very small quantity of MDMA in combination with Flouroamphetamine and 25C-NBOMe.

For full details please see the ACTINOS Ultra Alert (click to view/download the pdf).

Any questions should be directed to Dr David Caldicott, mobile: 0478 906 634

Share this post

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email

Innovative psychedelic research

The re-emergence of psychedelic research places a crucial emphasis on a holistic approach to mental health from pharmacology, neurobiological process, ecological connection, and therapeutic support.  PRISM supports research and clinical development of therapies where current options provide limited relief.

Your support allows us to pursue cutting edge research for next-generation mental health care.

PRISM

We are a DGR-1 non-profit research charity developing medical and legal processes for the application of psychedelic medicines for improved wellbeing.

Newsletter

Contact Us

Send us an email and we'll get back to you soon.

Not readable? Change text. captcha txt

Start typing and press Enter to search